Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GLP-1 on insulin dose, hypoglycemia risk and gastric emptying in type 1 diabetes mellitus
2009-011930-80Phase 2Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jun 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of liraglutide in diabetes mellitus type 1 (T1D), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Insulin dose (IE/day). Started Jun 2009; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-011930-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011930-80.